PURPOSE: To evaluate the efficacy of diode laser contact transscleral pars plana photocoagulation (CTPPP) for intraocular pressure (IOP) control in @entity726 and its clinical application. METHOD: A prospective, non-randomized hospital-based pilot study was conducted. Fourteen @entity1 with poor visual acuity (VA worse than 6/60) and medically uncontrolled, refractory @entity726 were recruited, and CTPPP was performed after informed consent. RESULTS: Mean preoperative IOP was 41.0 mmHg (SD 12.6, range 27-70, n = 14). At 1 week postoperatively, IOP was reduced in 12 of 14 (86%) @entity1 to a mean of 28.6 mmHg (SD 15.8, range 3-55, n = 14). This represented a mean decrease of 12.4 mmHg. Mean IOP was 34.0 mmHg (SD 17.4, range 5-71, n = 14) and 31.6 mmHg (SD 13.4, range 5-22, n = 12) at 4 and 12 weeks, respectively. The IOP reduction was significant at 1 week (P = 0.001, paired t-test) and at 12 weeks (P = 0.04, paired t-test). The two @entity1 with @entity158 reported @entity158 after the procedure. Seven of 13 @entity1 on @entity735 did not require eye drops postoperatively. CONCLUSION: Diode laser CTPPP was found to significantly reduce IOP in the majority of @entity1 at 1 week postoperatively, with less but still significant effect at 12 weeks. Its potential application as a procedure for short-term IOP reduction in medically uncontrolled @entity726 requiring filtering surgery needs to be further investigated.

Effect of diode laser contact transscleral pars plana photocoagulation on intraocular pressure in XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity735 :: ('MESH:D005124', 'Disease') :: ['preoperative antiglaucoma eye drops'] @entity726 :: ('MESH:D005901', 'Disease') :: ['glaucoma'] @entity158 :: ('MESH:D010146', 'Disease') :: ['abolition of pain', 'preoperative pain']
@entity726 :: (MESH:D005901,Disease) :: ['glaucoma']
